$470 Million is the total value of Ghost Tree Capital, LLC's 55 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 48.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PTCT | Sell | PTC THERAPEUTICS INC | $23,500,000 | +3.2% | 500,000 | -25.9% | 5.00% | -25.5% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $20,503,000 | -16.8% | 435,300 | -12.9% | 4.36% | -39.9% |
| IMMU | Sell | IMMUNOMEDICS INC | $18,410,000 | -37.8% | 883,823 | -29.3% | 3.91% | -55.1% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $15,316,000 | -25.9% | 175,000 | -16.7% | 3.26% | -46.5% |
| BLUE | Sell | BLUEBIRD BIO INC | $10,950,000 | -33.6% | 75,000 | -28.6% | 2.33% | -52.0% |
| ACAD | Sell | ACADIA PHARMACEUTICALS INC | $10,380,000 | +27.1% | 500,000 | -6.5% | 2.21% | -8.2% |
| ARGX | Sell | ARGENX SEsponsored adr | $9,480,000 | -23.7% | 125,000 | -16.7% | 2.02% | -44.9% |
| VRAY | Sell | VIEWRAY INC | $7,020,000 | +12.7% | 750,000 | -16.7% | 1.49% | -18.6% |
| MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $3,041,000 | -53.7% | 14,200 | -39.6% | 0.65% | -66.6% |
| NEOS | Sell | NEOS THERAPEUTICS INC | $2,341,000 | -37.6% | 482,600 | -19.6% | 0.50% | -54.9% |
| CBIO | Sell | CATALYST BIOSCIENCES INC | $2,156,000 | -48.0% | 200,000 | -43.7% | 0.46% | -62.4% |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $456,000 | -95.8% | 12,000 | -95.0% | 0.10% | -97.0% |
| TGTX | Sell | TG THERAPEUTICS INC | $255,000 | -62.7% | 45,500 | -12.5% | 0.05% | -73.1% |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO Lcall | $0 | – | -2,000 | -100.0% | -0.04% | – |
| LCI | Exit | LANNET INCcall | $0 | – | -2,000 | -100.0% | -0.15% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -14,000 | -100.0% | -0.24% | – |
| ACOR | Exit | ACORDA THERAPEUTICS INC | $0 | – | -33,000 | -100.0% | -0.28% | – |
| LCI | Exit | LANNET INC | $0 | – | -250,000 | -100.0% | -1.00% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -360,000 | -100.0% | -1.36% | – |
| BOLD | Exit | AUDENTES THERAPEUTICS INC | $0 | – | -125,000 | -100.0% | -1.41% | – |
| AVRO | Exit | AVROBIO INC | $0 | – | -230,000 | -100.0% | -1.93% | – |
| ADMS | Exit | ADAMAS PHARMACEUTICALS INC | $0 | – | -295,000 | -100.0% | -2.24% | – |
| EXEL | Exit | EXELIXIS INC | $0 | – | -400,000 | -100.0% | -2.53% | – |
| ARWR | Exit | ARROWHEAD PHARMACEUTICALS IN | $0 | – | -700,000 | -100.0% | -2.80% | – |
| MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -600,000 | -100.0% | -3.15% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2020-04-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.